Evidence map›Paper›PMID 39450040›Full record

ArticleMedical science educator2024

A Working Framework to Address Diversity, Equity, and Inclusion in Undergraduate Medical Education.

K Jiang, J B Blumer, N T Zaveri, S D Schneid, E M Lee, J L Szarek, M Kruidering, K M Quesnelle, M W Lee

Abstract read
In one paragraph

Article in Medical science educator, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

K JiangDepartment of Medical Education, Geisel School of Medicine, Dartmouth College, Remsen 232, 66 College Street, Hanover, USA.
J B BlumerDepartment of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, USA.
N T ZaveriDepartment of Pharmacology, Arkansas Colleges of Health Education, Fort Smith, USA.
S D SchneidSkaggs School of Pharmacy and Pharmaceutical Sciences & School of Medicine, University of California San Diego, San Diego, USA.
E M LeeDepartment of Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, USA.
J L SzarekDepartment of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, USA.
M KruideringDepartment of Cellular & Molecular Pharmacology, School of Medicine, University of California, San Francisco, San Francisco, USA.
K M QuesnelleDepartment of Biomedical Sciences, University of South Carolina School of Medicine Greenville, Greenville, USA.
M W LeeDepartment of Medical Education, Geisel School of Medicine, Dartmouth College, Remsen 232, 66 College Street, Hanover, USA.ORCID 0000-0001-8954-2057

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Health disparities exist among groups that are based on race, ethnicity, gender, socioeconomic status, and geography. Often, interventions directed at addressing these disparities are episodically incorporated into health professions education as opposed to a more uniform integration throughout a curriculum. Thus, a working framework for integrating and assessing diversity, equity, and inclusion (DEI) specifically into foundational science teaching in health professions' education is needed. Current frameworks are theoretically based and often bereft of practical examples that basic science and clinical educators would find useful in educational settings. Here we analyzed examples in pharmacology, therapeutics, and clinical medicine to create a tool aimed at identifying and remediating biases and disparities across the undergraduate medical education (UME) curriculum. We initially focused on pharmacology examples and performed a literature search followed by an in-depth analysis of the literature together with our experiences teaching topics with a DEI component. It became clear that, in addition to pure pharmacology topics, there are many pharmacology- and therapeutics-related topics that also involve race, gender, and sexual orientation. These include clinical guidelines and clinical screening criteria. Further analysis of all of the examples derived from our multi-faceted analysis revealed common themes that we, in turn, compiled into a framework. This framework can be used by foundational science and clinical educators to help both students and faculty understand how to navigate DEI-associated foundational science content.

Indexed as

DiversityGenderInclusionMedical educationPhIG

Identifiers

PMID39450040
PMCPMC11496410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.